Rekha Hemrajani insider trades
Open-market stock purchases and sales by Rekha Hemrajani, Unknown at Maxcyte, Inc, from SEC Form 4 filings since Mar 25, 2019.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -18%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | MXCT Maxcyte, Inc | Bought (not open market) | — |
| Jun 17, 2026 | MXCT Maxcyte, Inc | Bought (not open market) | — |
| Jun 10, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 3, 2026 | LBRX LB Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 20, 2026 | ALXO ALX Oncology Holdings Inc | Bought (not open market) | — |
Companies traded
- MXCT Maxcyte, Inc: 1 sale, last Jun 17, 2026
- BIOA BioAge Labs, Inc: 1 buy, last Jun 10, 2026
- LBRX LB Pharmaceuticals Inc: other filings, last Jun 3, 2026
- ALXO ALX Oncology Holdings Inc: 2 buys, last Jan 20, 2026
- ADVM Adverum Biotechnologies, Inc: other filings, last Jun 23, 2020
- ARAV Aravive, Inc: other filings, last Apr 8, 2020
- RCUS Arcus Biosciences, Inc: other filings, last Mar 25, 2019